In conclusion, we showed that the baseline expression levels of several circulating immunogenic proteins are correlated with PFS: in patients with stage I NSCLC, CD244 was identified as a potential negative prognostic biomarker. The gene discussed is CD244; the disease is non-small cell lung carcinoma.